Cargando…
Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible
When tissue biopsy is not medically prudent or tissue is insufficient for molecular testing, alternative methods are needed. Because cell-free DNA (cfDNA) has been shown to provide a representative surrogate for tumor tissue, we sought to evaluate its utility in this clinical scenario. cfDNA was iso...
Autores principales: | Jensen, Taylor J., Goodman, Aaron M., Ellison, Christopher K., Holden, Kimberly A., Kato, Shumei, Kim, Lisa, Daniels, Gregory A., Fitzgerald, Kerry, McCarthy, Erin, Nakashe, Prachi, Mazloom, Amin R., Almasri, Eyad, McLennan, Graham, Grosu, Daniel S., Eisenberg, Marcia, Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398131/ https://www.ncbi.nlm.nih.gov/pubmed/34465593 http://dx.doi.org/10.1158/1535-7163.MCT-20-1066 |
Ejemplares similares
-
A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas
por: Shah, Avanthi Tayi, et al.
Publicado: (2021) -
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel
por: Olson, N. Eric, et al.
Publicado: (2023) -
Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
por: Georgiev, Peter, et al.
Publicado: (2022) -
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study
por: Osada, Takuya, et al.
Publicado: (2022) -
Monitoring Circulating Tumor DNA During Surgical Treatment in Patients with Gastrointestinal Stromal Tumors
por: Johansson, Gustav, et al.
Publicado: (2021)